Sleep Disorders

 

 Buy Article Permissions and Reprints

ABSTRACT

Patients with sleep disorders present with a variety of complaints including excessive daytime sleepiness, daytime spells, inability to sleep, uncomfortable sensation in the extremities, and unusual night time behaviors. This article provides eight vignettes on patients with sleep disorders including narcolepsy, idiopathic hypersomnia, obstructive sleep apnea, restless legs syndrome, and rapid eye movement behavior disorder. The discussion provides data regarding the epidemiology, pathophysiology, and diagnostic approach for these conditions. The various treatment options for these sleep disorders are also identified.

REFERENCES

• 1 Silber M, Krahn L, Olson E, Pankratz V. Epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study.  Sleep . 2001;  24 A98
  PubMedGoogle Scholar
• 2 Krahn L, Boeve B, Olson E, Herold D, Silber M. A standardized test for cataplexy.  Sleep Med . 2000;  1 125-130
  PubMedGoogle Scholar
• 3 Broughton R, Guberman A, Roberts J. Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: a controlled study.  Epilepsia . 1984;  25 423-433
  PubMedGoogle Scholar
• 4 Silber M, Krahn L, Olson E, Pankratz V. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study.  Sleep . 2002;  25 197-202
  PubMedGoogle Scholar
• 5 Mignot E, Hayduk R, Black J, Grumet F, Guilleminault C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.  Sleep . 1997;  20 1012-1020
  PubMedGoogle Scholar
• 6 Chervin R, Dillon J, Bassetti C, Ganoczy D, Pituch K. Symptoms of sleep disorders, inattention, and hyperactivity in children.  Sleep . 1997;  20 1185-1192
  PubMedGoogle Scholar
• 7 Krahn L, Hansen M, Shepard J. Pseudocataplexy.  Psychosomatics . 2001;  42 356-358
  CrossrefPubMedGoogle Scholar
• 8 Krahn L, Black J, Silber M. Narcolepsy: new understanding of irresistible sleep.  Mayo Clin Proc . 2001;  76 185-194
  PubMedGoogle Scholar
• 9 Overeem S, Mignot E, Gert van Dijk J, Lammers G. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives.  J Clin Neurophysiol . 2001;  18 78-105
  CrossrefPubMedGoogle Scholar
• 10 Black J, Krahn L, Silber M. A pilot study of serologic markers of autoimmunity in patients with narcolepsy.  Sleep . 2001;  24 A318-A319
  PubMedGoogle Scholar
• 11 Thannickal T, Moore R, Nienhuis R. et al . Reduced number of hypocretin neurons in human narcolepsy.  Neuron . 2000;  27 469-474
  CrossrefPubMedGoogle Scholar
• 12 Nishino S, Ripley B, Overeem S, Lammers G, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy (letter).  Lancet . 2000;  355 39-40
  CrossrefPubMedGoogle Scholar
• 13 Schuld A, Blum W, Pollmacher T. Low CSF hypocretin (orexin) and altered energy metabolism in human narcolepsy.  Ann Neurol . 2002;  51 660-661
  PubMedGoogle Scholar
• 14 Mignot E, Lammers G, Ripley B. et al . The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.  Arch Neurol . 2002;  59 1553-1562
  CrossrefPubMedGoogle Scholar
• 15 Smart D, Jerman J. The physiology and pharmacology of the orexins.  Pharmacol Ther . 2002;  94 51-61
  CrossrefPubMedGoogle Scholar
• 16 US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy.  Ann Neurol . 1998;  43 88-97
  CrossrefPubMedGoogle Scholar
• 17 Scharf M, Lai A, Branigan B, Stover R, Berkowitz D. Pharmacokinetics of gammahydroxybutyrate (GHB) in narcoleptic patients.  Sleep . 1998;  21 507-514
  PubMedGoogle Scholar
• 18 Zyrem Multicenter Study Group. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.  Sleep . 2002;  25 42-49
  CrossrefPubMedGoogle Scholar
• 19 Mitler M, Shafor R, Hajdukovich R, Timms R, Browman C. Treatment of narcolepsy: objective studies on methylphenidate, pemoline, and protriptyline.  Sleep . 1986;  9 260-264
  PubMedGoogle Scholar
• 20 Billiard M, Merle C, Carlander B, Ondze B, Alvarez D, Besset A. Idiopathic hypersomnia.  Psychiatry Clin Neurosci . 1998;  52 125-129
  PubMedGoogle Scholar
• 21 Bassetti C, Aldrich M. Idiopathic hypersomnia: a series of 42 patients.  Brain . 1997;  120 1423-1435
  CrossrefPubMedGoogle Scholar
• 22 Kanbayashi T, Inque Y, Chiba S. et al . CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.  J Sleep Res . 2002;  11 91-93
  CrossrefPubMedGoogle Scholar
• 23 Walker R. Long-term health consequences of mild to moderate obstructive sleep apnea.  Arch Otolaryngol Head Neck Surg . 2001;  127 1397-1400
  PubMedGoogle Scholar
• 24 Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults.  N Engl J Med . 1993;  328 1230-1235
  CrossrefPubMedGoogle Scholar
• 25 Young T, Peppard P, Gottlieb D. Epidemiology of obstructive sleep apnea: a population health perspective.  Am J Respir Crit Care Med . 2002;  165 1217-1239
  CrossrefPubMedGoogle Scholar
• 26 Partinen M. Epidemiology of obstructive sleep apnea syndrome.  Curr Opin Pulm Med . 1995;  1 482-487
  PubMedGoogle Scholar
• 27 Rama A, Tekwani S, Kushida C. Sites of obstruction in obstructive sleep apnea.  Chest . 2002;  122 1139-1147
  CrossrefPubMedGoogle Scholar
• 28 Dart R, Gregoire J, Gutterman D, Woolf S. The association of hypertension and secondary cardiovascular disease with sleep-disordered breathing.  Chest . 2003;  123 244-260
  CrossrefPubMedGoogle Scholar
• 29 Bananian S, Lehrman S, Maguire G. Cardiovascular consequences of sleep-related breathing disorders.  Heart Dis . 2002;  4 296-305
  PubMedGoogle Scholar
• 30 Loh N, Dinner D, Foldvary N, Skobieranda F, Yew W. Do patients with obstructive sleep apnea wake up with headaches?.  Arch Intern Med . 1999;  159 1765-1768
  CrossrefPubMedGoogle Scholar
• 31 Dodick D, Eross E, Parish J. Clinical, anatomical, and physiologic relationship between sleep and headache.  Headache. ;  34 282-292
  PubMedGoogle Scholar
• 32 Berry R, Parish J, Hartse K. The use of auto-titrating continuous positive airway pressure for the treatment of adult obstructive sleep apnea: an American Academy of Sleep Medicine review.  Sleep . 2002;  25 148-173
  PubMedGoogle Scholar
• 33 Sullivan C, Grunstein R. Continuous positive airway pressure in sleep-disordered breathing. In: Kryger M, Roth T, Dement W, eds. Principles and Practice of Sleep Medicine 2nd ed. Philadelphia: WB Saunders 1994: 694
  Google Scholar
• 34 Clark G, Blumenfeld I, Yoffe N, Peled E, Lavie P. A crossover study comparing the efficiency of continuous positive airway pressure with anterior mandibular positioning devices on patients with obstructive sleep apnea.  Chest . 1996;  109 1477-1483
  PubMedGoogle Scholar
• 35 Flemons W. Obstructive sleep apnea.  N Engl J Med . 2002;  347 498-504
  Google Scholar
• 36 Lojander P, Maasilta P, Partinen M, Brander P, Salmi T, Lehtonen H. Nasal-CPAP and conservative management for treatment of obstructive sleep apnea syndrome: a randomized study.  Chest . 1996;  110 114-119
  PubMedGoogle Scholar
• 37 Littner M, Kushida C, Hartse K. et al . Practice parameters for the use of laser-assisted uvulopalatoplasty: an update for 2000.  Sleep . 2001;  24 603-619
  PubMedGoogle Scholar
• 38 Berry R, Deas M, Light R. Effect of ethanol on the efficacy of nasal continuous positive airway pressure as a treatment for obstructive sleep apnea.  Chest . 1991;  99 339-341
  PubMedGoogle Scholar
• 39 Dolly F, Block A. Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects.  Am J Med . 1982;  73 239-243
  CrossrefPubMedGoogle Scholar
• 40 Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic and genetic characteristics of restless legs syndrome: a study of 133 patients with new standard criteria.  Move Disord . 1997;  12 61-65
  CrossrefPubMedGoogle Scholar
• 41 Chaudhuri K, Appiah-Kubi L, Trenkwalder C. Restless legs syndrome.  J Neurol Neurosurg Psychiatry . 2001;  71 143-146
  CrossrefPubMedGoogle Scholar
• 42 Nicolas A, Michaud M, Lavigne G, Montplaisir J. The influence of sex, age and sleep/wake state on characteristics of periodic leg movements in restless legs syndrome patients.  J Clin Neurophysiol . 1999;  110 1168-1174
  PubMedGoogle Scholar
• 43 Phillips B, Young T, Finn L, Asher K, Hening W, Purvis C. Epidemiology of restless legs syndrome in adults.  Arch Intern Med . 2000;  160 2137-2141
  CrossrefPubMedGoogle Scholar
• 44 Ohayon M, Roth T. Prevalence of restless legs syndrome and periodic movement disorder in the general population.  J Psychosom Res . 2002;  53 547-554
  CrossrefPubMedGoogle Scholar
• 45 Desautels A, Turecki G, Montplaisir J, Sequeira A, Verner A, Rouleau G. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q.  Am J Hum Genet . 2001;  69 1266-1270
  CrossrefPubMedGoogle Scholar
• 46 Bonati M, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G. Autosomal dominant restless legs syndrome maps on chromosome 14q.  Brain . 2003;  126 1485-1492
  CrossrefPubMedGoogle Scholar
• 47 Winkelmann J, Chertow G, Lazarus J. Restless legs syndrome in end-stage renal disease.  Am J Kidney Dis . 1996;  28 372-378
  CrossrefPubMedGoogle Scholar
• 48 Takaki J, Nishi T, Nangaku M. et al . Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis.  Am J Kidney Dis . 2003;  41 833-839
  PubMedGoogle Scholar
• 49 Ruottinen H, Partinen M, Hublin C. et al . An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome.  Neurology . 2000;  54 502-504
  PubMedGoogle Scholar
• 50 Earley C, Allen R, Beard J, Connor J. Insight into the pathophysiology of restless legs syndrome.  J Neurosci Res . 2000;  62 623-628
  CrossrefPubMedGoogle Scholar
• 51 Allen R, Earley C. Restless legs syndrome: a review of clinical and pathophysiologic features.  J Clin Neurophysiol . 2001;  18 128-147
  PubMedGoogle Scholar
• 52 Comella C. Restless legs syndrome: treatment with dopaminergic agents.  Neurology . 2002;  58 S87-S92
  PubMedGoogle Scholar
• 53 Saletu M, Anderer P, Saletu-Zyhlarz G, Hauer C, Saletu B. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.  Eur Arch Psychiatry Clin Neurosci . 2002;  252 185-194
  PubMedGoogle Scholar
• 54 Pritchett A, Morrison J, Edwards W D, Schaff H, Connolly H, Espinosa R. Valvular heart disease in patients taking pergolide.  Mayo Clin Proc . 2002;  77 1280-1286
  PubMedGoogle Scholar
• 55 Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study.  Neurology . 2002;  59 1573-1579
  CrossrefPubMedGoogle Scholar
• 56 Walters A, Winkelmann J, Trenkwalder C. et al . Long-term follow-up on restless legs syndrome patients treated with opioids.  Move Disord . 2001;  16 1105-1109
  PubMedGoogle Scholar
• 57 Davis B, Rajput A, Rajput M, Aul E, Eichhorn G. A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome.  Eur Neurol . 2000;  43 70-75
  CrossrefPubMedGoogle Scholar
• 58 Schenck C, Bundlie S, Ettinger M, Mahowald M. Chronic behavioral disorders of human REM sleep: a new category of parasomnia.  Sleep . 1986;  9 293-308
  PubMedGoogle Scholar
• 59 Schenck C, Hurwitz T, Mahowald M. Symposium: normal and abnormal REM sleep regulation: REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature.  Sleep . 1993;  2 224-231
  PubMedGoogle Scholar
• 60 Olson E, Boeve B, Silber M. Rapid eye movement sleep behavior disorder: demographic, clinical and laboratory findings in 93 cases.  Brain . 2000;  123 331-339
  Google Scholar
• 61 Schenck C, Mahowald M, Kim S, O'Connor K, Hurwitz T. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder.  Sleep . 1992;  15 226-235
  PubMedGoogle Scholar
• 62 Comella C, Nardine T, Diedrich N, Stebbins G. Sleep-related violence, injuries and REM behavior disorder in Parkinson's disease.  Neurology . 1998;  51 526-529
  PubMedGoogle Scholar
• 63 Plazzi G, Corsini R, Provini F. et al . REM behavior disorder in multiple system atrophy.  Neurology . 1997;  48 1094-1097
  CrossrefPubMedGoogle Scholar
• 64 Boeve B, Silber M, Ferman T, Lucas J, Parisi J. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.  Move Disord . 2001;  16 622-630
  CrossrefPubMedGoogle Scholar
• 65 Schenck C, Mahowald M. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults.  Am J Med . 1996;  100 333-337
  CrossrefPubMedGoogle Scholar